Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Pude Pharmaceutical, also referred to historically as Shanxi Powerdone Pharmaceutics, is a China-based commercial pharmaceutical manufacturer focused primarily on chemical drug products, compound preparations, and sterile injectable formulations. The company operates integrated manufacturing, quality control, and animal laboratory capabilities and has built substantial GMP-certified production capacity in Datong, Shanxi. Its business appears centered on approved and marketed generic and hospital-use products rather than a novel clinical-stage biotech pipeline, and it also promotes integrated CMO services for partners covering registration support, manufacturing, and commercialization support. Historically, the company was acquired by Harbin Gloria Pharmaceuticals and now operates as an acquired pharmaceutical manufacturing business. The company is active and continues to present itself publicly under the Pude Pharmaceutical brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Pude Pharmaceutical.